Search research articles
Contact Us
Filters
Showing results (431-440 of 602) with videos related to
Page
of 61
Sort By:
Cold Spring Harbor Symposia on Quantitative Biology
|
January 1, 1994
Exploiting multidrug resistance to treat cancer
M M Gottesman, S V Ambudkar, B Ni, et al.
British Journal of Cancer
|
January 1, 1996
MDA435/LCC6 and MDA435/LCC6MDR1: ascites models of human breast cancer
F Leonessa, D Green, T Licht, et al.
Biochemical and Biophysical Research Communications
|
December 30, 1986
The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein
K Ueda, M M Cornwell, M M Gottesman, et al.
Cancer Gene Therapy
|
February 25, 2006
SV40 Pseudovirion gene delivery of a toxin to treat human adenocarcinomas in mice
C Kimchi-Sarfaty, W D Vieira, D Dodds, et al.
Molecular Pharmaceutics
|
April 20, 2013
Factors that limit positron emission tomography imaging of p-glycoprotein density at the blood-brain barrier
Pavitra Kannan, Victor W Pike, Christer Halldin, et al.
Human Gene Therapy
|
April 29, 1998
Efficient transduction of human hematopoietic cells with the human multidrug resistance gene 1 via SV40 pseudovirions
D Rund, M Dagan, N Dalyot-Herman, et al.
The Journal of Gene Medicine
|
May 6, 2003
Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91
Yoshikazu Sugimoto, Satomi Tsukahara, Shigeo Sato, et al.
Biochemical and Biophysical Research Communications
|
January 15, 1990
Use of recombinant P-glycoprotein fragments to produce antibodies to the multidrug transporter
S Tanaka, S J Currier, E P Bruggemann, et al.
International Journal of Cancer
|
February 3, 2005
Co-expression of alternatively spliced forms of PAX3, PAX7, PAX3-FKHR and PAX7-FKHR with distinct DNA binding and transactivation properties in rhabdomyosarcoma
Shouying Du, Eric J Lawrence, Donna Strzelecki, et al.
Cancer Research
|
October 27, 1998
P-glycoprotein plays an insignificant role in the presentation of antigenic peptides to CD8+ T cells
G Russ, M Ramachandra, C A Hrycyna, et al.
Page
of 61
Search research articles
Search
Showing results (431-440 of 602) with videos related to
Sort By:
Page
of 61
Cold Spring Harbor Symposia on Quantitative Biology
|
January 1, 1994
Exploiting multidrug resistance to treat cancer
M M Gottesman, S V Ambudkar, B Ni, et al.
British Journal of Cancer
|
January 1, 1996
MDA435/LCC6 and MDA435/LCC6MDR1: ascites models of human breast cancer
F Leonessa, D Green, T Licht, et al.
Biochemical and Biophysical Research Communications
|
December 30, 1986
The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein
K Ueda, M M Cornwell, M M Gottesman, et al.
Cancer Gene Therapy
|
February 25, 2006
SV40 Pseudovirion gene delivery of a toxin to treat human adenocarcinomas in mice
C Kimchi-Sarfaty, W D Vieira, D Dodds, et al.
Molecular Pharmaceutics
|
April 20, 2013
Factors that limit positron emission tomography imaging of p-glycoprotein density at the blood-brain barrier
Pavitra Kannan, Victor W Pike, Christer Halldin, et al.
Human Gene Therapy
|
April 29, 1998
Efficient transduction of human hematopoietic cells with the human multidrug resistance gene 1 via SV40 pseudovirions
D Rund, M Dagan, N Dalyot-Herman, et al.
The Journal of Gene Medicine
|
May 6, 2003
Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91
Yoshikazu Sugimoto, Satomi Tsukahara, Shigeo Sato, et al.
Biochemical and Biophysical Research Communications
|
January 15, 1990
Use of recombinant P-glycoprotein fragments to produce antibodies to the multidrug transporter
S Tanaka, S J Currier, E P Bruggemann, et al.
International Journal of Cancer
|
February 3, 2005
Co-expression of alternatively spliced forms of PAX3, PAX7, PAX3-FKHR and PAX7-FKHR with distinct DNA binding and transactivation properties in rhabdomyosarcoma
Shouying Du, Eric J Lawrence, Donna Strzelecki, et al.
Cancer Research
|
October 27, 1998
P-glycoprotein plays an insignificant role in the presentation of antigenic peptides to CD8+ T cells
G Russ, M Ramachandra, C A Hrycyna, et al.
Page
of 61